In the biotech, the VCs are more interested in investing in a technology with huge upside and less interested in the individuals attached to the technology at that moment, because they can build the team around the technology. Companies established in Pharmaceutical companies of the United States Privately held companies based in Massachusetts Companies based in Boston Biotechnology companies Health care companies based in Massachusetts. What features of the technology did you look at to decide that vaccine stabilization was the best application of silk protein? Under that approach a company will get insights from someone who is not working on a particular project team but has some other inspiration that they can draw on to make that program better. Retrieved 22 March
Immuno-oncology is one field that you hear about and the fundamental challenge is the same – we need to generate a very strong immune response to particular antigens. Retrieved 4 February What spurred your decision to apply to business school? Zumper will help connect landlords and brokers to qualified tenants, while also helping those tenants search for and close annual apartment leases in a much more transparent manner. So what types of ventures made the cut this year?
First, vaccines that can be stored basically anywhere through our stabilization technology.
Tufts has published a ton of papers on this protein and all the different things you can do with it. The technology of silk biomaterials was fairly mature from an academic standpoint. Retrieved 5 May What is businness long-term vision for the company? Archived from the original on 12 May Valenti attended the John F.
Zumper will help connect landlords and brokers to qualified tenants, while also helping those tenants search for technoligies close annual apartment leases in a much more transparent manner. Having exposure to those different management philosophies – again, all great companies where tschnologies system works for them – has helped us think more about the culture and organizational behavior we want to develop at Vaxess.
Michael Schrader is co-founder and CEO of Vaxess Technologies, an innovative Cambridge-based company revolutionizing vaccine stabilization and delivery through the development of novel silk-based technologies both in-house as well as through partnerships with leading vaccine and biopharma companies.
Still in stealth mode, this bbusiness platform wants to change how tenants rent businses estate. The auto industry background, quite frankly, has helped very, very little with the technical challenges we encounter in vaccine stabilization. Retrieved 4 June Vaxess won first place in the Transportation category, above HopOn and Matternet. What skills and insights from your work in the auto industry have come in useful as the CEO of Vaxess?
For example, we recently started working with MIT professors Darrell Irvine and Paula Hammond on a silk microneedle design that came out of their labs. We know how it acts in the human body, how it degrades, and we know its inflammatory and immunological profiles. I think I have a sense of what your company needs.
Retrieved 22 March Changing these parameters can tease the silk material to self-assemble into everything from gels baxess very solid constructs. SaferTaxi aims to bring greater efficiency and safety to the existing taxi booking process. P,an being an expert in the field of vaccinology and Middaugh being an expert in the fields of in the fields of biophysical chemistry and pharmaceutical formulation.
We knew little about RNA – we had never worked with it. I could do corporate strategy and product planning way better than is currently done. Regarding vaccines, one of our targets is the polio vaccine. Under that approach a company will get insights from someone who is not working on tefhnologies particular project team but has some other inspiration that they can draw on to make that program better.
Michael Schrader – SYNAPSE
Having a diverse, capable team is the other important element of startups. This page was last edited on 14 Decemberat Retrieved 8 July I started in the world of manufacturing, and if you ever have the chance to work at a manufacturing plant, every line worker and engineer in a manufacturing plant will complain about how crummy the designs they get are.
Think of the way this protein behaves in nature: For example, orthopedic screws have even been made from this protein.
Resources Spotlight interviews Company profiles Incubators and accelerators About. This venture is working to commercialize a Tufts University technology that stabilizes vaccines into a thin film strip which can be shipped and stored without refrigeration, eliminating the need for a cold chain.
The other thing is that I’ve seen very bisiness approaches to management between my time in the auto industry and my brief internship in the tech sector. Kennedy School of Government.